New Melt-in-Mouth trimedat put to the test
NCT ID NCT07421011
First seen Feb 21, 2026 · Last updated May 18, 2026 · Updated 15 times
Summary
This study checks if a new orally disintegrating tablet of Trimedat (76.95 mg) works the same as the standard 100 mg tablet in 36 healthy adults. Participants take both forms at different times to compare how the drug is absorbed and processed. The goal is to see if the new version is a safe and effective alternative for people with digestive issues like IBS or GERD.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Federal Budgetary Institution of Science "North-West Public Health Research Center"
RECRUITINGSaint Petersburg, 191036, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.